Previous 10 | Next 10 |
Bitdeer Technologies Group (BTDR) is expected to report $0.11 for Q4 2023 BioForce Nanosciences Holdings Inc (BFNH) is expected to report for Q4 2023 Casino Guichard Perrachon ADR (CGUSY) is expected to report for quarter end 2023-12-31 Motorsport Games Inc. (MSGM) is expected to repo...
Tredegar Corporation (TG) is expected to report for quarter end 2023-12-31 Pharma-Bio Serv Inc (PBSV) is expected to report $0.02 for Q1 2024 Telos Corporation (TLS) is expected to report $-0.18 for Q4 2023 Coretec Group Inc (CRTG) is expected to report for quarter end 2023-12-31 ...
Company advancing an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases Ongoing efforts to build a robust global patent estate for a growing pipeline targeting high-value indications in need of innovation LA JOLLA, CA, Ma...
Genesco Inc. (GCO) is expected to report $2.66 for Q4 2024 Broadway Financial Corporation (BYFC) is expected to report for quarter end 2023-12-31 Oji Holdings Corporation ADR (OJIPY) is expected to report for Q3 2024 Hibbett Inc. (HIBB) is expected to report $2.54 for Q4 2024 GRI ...
MHRA authorization expands ongoing U.S. Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (“IPF”) with interim data expected H1 2024 and topline data H2 2024 UK enrollment to be supported by collaboration with UK con...
Eurofins Scientific S.E. (ERFSF) is expected to report for Q4 2023 Biodesix Inc. (BDSX) is expected to report $-0.1 for Q4 2023 Tapinator Inc (TAPM) is expected to report for quarter end 2023-12-31 Rapid Micro Biosystems Inc. (RPID) is expected to report $-0.31 for Q4 2023 Galapag...
Oversea-Chinese Banking Corporation Limited ADR (OVCHY) is expected to report for Q4 2023 Real Brands Inc (RLBD) is expected to report for Q4 2023 NovelStem International Corp (NSTM) is expected to report for Q4 2023 Docebo Inc. (DCBO) is expected to report $0.12 for Q4 2023 Basf ...
2024-02-05 10:00:03 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Lilly, Zoetis, Abbott least shor...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) fell 5.0% to $11.72 on volume of 189,765,259 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 3.8% to $5.09 on volume of 143,664,257 shares Amazon.com Inc. (AMZN) rose 7.9% to $171.81 on volume of ...
2024-02-05 08:25:25 ET More on pre-market losers & stocks. Livent: Undervalued With Significant Upside Potential Livent: Wonderful Company Fairly Valued Livent And Albemarle: 2 Lithium Stocks To Buy Now Livent and Allkem shareholders approve merger of equ...
News, Short Squeeze, Breakout and More Instantly...
Cohen & Steers Global Realty Majors Company Name:
GRI Stock Symbol:
NYSE Market:
Cohen & Steers Global Realty Majors Website:
Data demonstrates that NKT cells are activated in airways in IPF patients and inhibition of type 1 invariant NKT (iNKT) cell activity can ameliorate bleomycin-induced pulmonary fibrosis in mice Compared to controls, mice treated with GRI-0621 showed histological improvement in fibrotic le...
LA JOLLA, CA, July 01, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic an...
LA JOLLA, CA, June 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic an...